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The Frustrations of Families: Henry Lynch, Heredity,
and Cancer Control, 1962–1975
DAVID CANTOR*
When Henry T Lynch thought that he had discovered the existence of hereditary cancers
among Nebraskan families in the 1960s, his hope was that it would lead to more effective
means of cancer control. Lynch argued that the identification of such cancers offered
tremendous opportunities for improving detection and treatment. If cancer ran in families,
he claimed, the discovery of a hereditary cancer in one family member should be an alert to
the possibility of cancer in others, and so prompt careful scrutiny for any signs that might
indicate the presence of the disease in ‘‘healthy’’ individuals. Lynch hoped that by targeting
cancer families it would be possible to catch more cancers at an earlier stage than was
hitherto possible. Cancers caught early were often curable, the American Cancer Society
(ACS) claimed.1
Today Lynch is widely regarded as one of the fathers of cancer genetics, notably for his
work on hereditary cancers of the breast and colon. However, in the 1960s and 1970s such
recognition was a long way away, and few would have predicted his current eminence.
Lynch worked (then, as now) at a small, unprestigious Catholic university in Omaha,
Nebraska, far from the major centres of cancer research, and his assertions about the
hereditary nature of some cancers were not greeted with the enthusiasm he might have
wished. Many cancer experts doubted his claim to have identified hereditary cancers, and
ACS education efforts routinely stated that cancer was not a hereditary disease. Thus,
Lynch’s scheme for improving cancer detection and treatment seemed to falter almost
before it began. These problems provide an opportunity to examine the relations of heredity
to cancer in the 1960s and early 1970s, and what they tell us about cancer control in those
years.2
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cure in twentieth-century America, New York, Oxford
University Press, 2001; and Lester Breslow, et al.,
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The fact of heredity’s marginality to cancer control in these decades will come as no
surprise to readers of this journal. It is well known that research excitement focused on viral
and environmental explanations of the disease.3 Despite vast programmes of laboratory
research on heredity in mice and other animals,4 the relatively few studies of heredity in
human populations were often greeted with scepticism by cancer experts, who found the
association between cancer and heredity unproven or insignificant.5 As importantly, I
argue, doubts about heredity also focused on the danger it posed to programmes of cancer
control. For years cancer experts had sought to wean the public off the belief that cancer
was a hereditary disease, fearing that it promoted either complacency or paralytic fear, and
so encouraged individuals to delay seeking help until after the best opportunities for
effective treatment were gone. To his critics, Lynch’s focus on hereditary cancers threa-
tened to perpetuate these problems, and consequently to undermine the very programmes
of control that he sought to improve.
If Lynch’s advocacy of heredity reveals concerns about the impact of hereditarian
beliefs on the public, it also reveals divisions over the moral responsibility for seeking
care. Robert Aronowitz has noted that the ‘‘do not delay’’ message of control programmes
tended to make individual patients responsible for obtaining help for their cancer, while at
the same time minimizing the responsibility of physicians.6 Lynch’s approach highlights
an alternative moral universe that saw individual choice restricted by powerful psycho-
dynamic forces, and that placed greater responsibility on the physician for ensuring that the
cancer control message got through. In his view, many physicians failed to address
patients’ emotional needs, and so tended to exacerbate the fear and stigma associated
with cancer, thus contributing to the problems of delay and what would come to be known
as compliance.7 Lynch’s efforts to shift responsibility, I argue, emerged out of a peculiar
3Robert N Proctor, Cancer wars: how politics
shapes what we know and what we don’t know about
cancer, New York, Basic Books, 1995; Stephen P
Strickland, Politics, science and dread disease: a short
history of United States medical research policy,
Cambridge, MA, Harvard University Press, 1972.
4 Ilana Lo¨wy and Jean-Paul Gaudilliere,
‘Disciplining cancer: mice and the practice of genetic
purity’, in Jean-Paul Gaudilliere and Ilana Lo¨wy (eds),
The invisible industrialist: manufactures and the
production of scientific knowledge, Basingstoke,
Macmillan, 1998, pp. 209–49; Jean-Paul Gaudilliere,
‘Circulating mice and viruses: the Jackson Memorial
Laboratory, the National Cancer Institute, and the
genetics of breast cancer, 1930–1965’, in Michael
Fortun and Everett Mendelsohn (eds), The practices
of human genetics, Dordrecht, Kluwer Academic
Publishers, 1999, pp. 89–124; Jean-Paul Gaudilliere,
‘Making heredity in mice and men: the production and
uses of animal models in postwar human genetics’, in
Jean-Paul Gaudilliere and Ilana Lo¨wy (eds), Heredity
and infection: the history of disease transmission,
London and NewYork, Routledge, 2001, pp. 181–202;
Jean-Paul Gaudilliere, ‘Mapping as technology: genes,
mutant mice, and biomedical research (1910–1965)’,
in Hans-Jo¨rg Rheinberger and Jean-Paul Gaudilliere
(eds), Classical genetic research and its legacy:
the mapping cultures of twentieth-century genetics,
London and New York, Routledge, 2004, pp. 173–203;
Karen A Rader, Making mice: standardizing animals
for American biomedical research, 1900–1955,
Princeton and Oxford, Princeton University Press,
2004, esp. chs 4 and 5.
5For one of the few exceptions to the dismissal
of hereditarian explanations of cancer, see Paolo
Palladino, ‘Between knowledge and practice: on
medical professionals, patients, and the making of the
genetics of cancer’, Soc. Stud. Sci., 2002, 32: 137–65.
See also Paolo Palladino, ‘Speculations on cancer-free
babies: surgery and genetics at St. Mark’s Hospital,
1924–1995’, in Gaudilliere and Lo¨wy (eds), Heredity
and infection, op. cit., note 4 above, pp. 285–310; and
Paolo Palladino, Plants, patients and the historian:
(re)membering in the age of genetic engineering,
New Brunswick, NJ, Rutgers University Press, 2003.
6Aronowitz, op. cit., note, 1 above, esp. pp. 370–5.
7 Jeremy A Greene, ‘Therapeutic infidelities:
‘noncompliance’ enters the medical literature,
1955–1975’, Soc. Hist. Med., 2004, 17: 327–43.
280
David Cantor
intersection of cancer, medical genetics and psychology that located problems of delay and
compliance in patterns of social—especially family—interactions much more than in the
biological or psychological characteristics of an individual.8 From such a perspective,
families could be the frustration of cancer control.
Henry T Lynch
Henry T Lynch was born in Lawrence, Massachusetts, on 4 January 1928.9 He grew up
in a poor section of New York City, dropped out of school at the age of fourteen, and, in
1944, tricked his way into the US Navy, using a cousin’s identification to make himself
seem older than his sixteen years. The subterfuge was discovered, but the Navy kept him on
for the duration of the Second World War. He served in Europe, and participated in the
liberation of the Philippines, but most of the time he ploughed the Pacific as a gunner on a
merchant marine ship. Discharged from the Navy in 1946, he became a professional boxer,
working predominantly in upper NewYork State and the San Francisco Bay area. After this
unusual beginning for a physician, he began training in the three areas that would dominate
his professional life in the 1960s and 1970s—psychology, genetics and medicine.
Lynch took a qualifying examination to complete his high school requirements, and
went to the University of Oklahoma in Norman aiming to become a clinical psychologist.
Graduating in 1951, he moved to the University of Denver in 1952 where he took a masters
degree in clinical psychology. He then began a PhD at the University of Texas, Austin
(1953–1956), majoring in human genetics (with minors in biochemistry and psychology)
under Clarence P Oliver (1898–1991), the one-time founder and director of the Dight
Institute for Human Genetics at the University of Minnesota.10 Abandoning the PhD,
8For the background of post-war enthusiasm for
psychology, see Nathan G Hale Jr, The rise and crisis
of psychoanalysis in the United States: Freud and the
Americans, 1917–1985, New York, Oxford University
Press, 1995; Ellen Herman, The romance of American
psychology: political culture in the age of experts,
Berkeley, University of California Press, 1995; Eva
SMoskowitz, In therapy we trust: America’s obsession
with self-fulfillment, Baltimore, Johns Hopkins
University Press, 2001; Joel Pfister and Nancy Schnog
(eds), Inventing the psychological: toward a cultural
history of emotional life in America, New Haven,
Yale University Press, 1997.
9 I am grateful to Dr Lynch for a copy of his CV.
An earlier version of his CV is available at
<http://tobaccodocuments.org/ctr/CTRMN011133-1160.
html> (accessed 18 July 2003). Details of his career are
also obtained from <http://www.whonamedit.com/
doctor.cfm/1970.html> (accessed 18 July 2003), and
from Eugene P DiMagno, ‘Lifetime Achievement
Award Henry T. Lynch,MD. International Symposium
on Inherited Diseases of the Pancreas’, in Peter Durie,
Markus M Lerch, Albert B Lowenfels, Patrick
Maisonneuve, Charles D Ulrich and David C
Whitcomb (eds), Genetic disorders of the exocrine
pancreas: an overview and update, Basel, Karger,
2002, pp. 149–53; ‘Henry Lynch’s family affair: on the
trail of inherited cancers’, Coping Magazine, May
1987, pp. 50–4; Mary McGrath, ‘Dr. Henry T. Lynch’,
Sunday World Herald [Omaha], 28 Nov. 1999, Section
R, p. 24. Details of his career are also from an interview
I conductedwithHenry Lynch, 12thDecember 2003, in
his office at Creighton University, hereafter ‘Lynch
interview, 12th December 2003’.
10Oliver moved to Austin in 1946, where he
established a human genetics programme at the
University of Texas and served as chair of the
department of zoology. Clarence P Oliver, ‘Human
genetics program at the University of Texas’,
Eugenical News, 1952, 37: 25–31. It is possible that
Lynch’s first contact with human or medical genetics
was during his time at Oklahoma where Lawrence
H Snyder and Paul R David provided genetic advice to
families referred to them. Snyder had been professor
in medical genetics at Ohio State University before
moving in 1947 to become Dean of the Graduate
College of the University of Oklahoma. David was
the Professor of Zoology also at the University of
Oklahoma. Daniel J Kevles, In the name of eugenics:
genetics and the uses of human heredity, Cambridge,
MA, Harvard University Press, 1995, pp. 209–10. For a
listing of North American counselling centres in the
1950s, see Lee RDice, ‘Heredity clinics: their value for
public service and for research’, American Journal of
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Lynch went on to study medicine at the University of Texas, Galveston, from where he
graduated in 1960. In succession he was an intern at St Mary’s Hospital, Evansville,
Indiana (1961); a resident in internal medicine at the University of Nebraska College
of Medicine, Omaha (1961–1964); and a USPHS fellow in clinical oncology at the Eppley
Institute for Research in Cancer and Allied Diseases, Omaha (1964–1966), during which
time he also held various lecturing positions in Lincoln, Nebraska.11 A brief appointment
followed as Assistant Professor of Biology and Assistant Internist in Medicine (Human
Genetics, and Medical Oncology) at the University of Texas, MD Anderson Hospital and
Human Genetics, 1952, 4: 1–13. A shorter version of
this article is available in Lee R Dice, ‘Counseling
centers on human heredity in North America’,
Eugenical News, 1952, 37: 32–34.
11These positions were: Medical Genetics
Consultant and Lecturer, Department of Orthodontics,
University of Nebraska College of Dentistry, Lincoln
(1962–1965), and Lecturer in Human Genetics,
Graduate and undergraduate students, Department of
Zoology, University of Nebraska, Lincoln
(1962–1964).
Figure 1: Henry Lynch as a young man. Undated photograph, probably taken in the 1940s.
(Henry Lynch archives. Reprinted with permission of Henry Lynch.)
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Tumor Institute in Houston (1966–1967). Then in 1967, he joined the faculty of the
Creighton University School of Medicine, Omaha, Nebraska, where he remains today.12
Lynch might have trained in human genetics, but his main interest was in its clinical
applications, what he labelled ‘‘medical genetics’’, a specialty that had emerged in the late
1950s as institutionally distinct from human genetics.13 While in Galveston in the late
1950s he helped set up a clinical genetics programme in the departments of Pediatrics and
Anatomy at the University of Texas Medical Branch, along with the paediatrician, Robert
L Tips, and the anatomist, C Wallace McNutt.14 From 1959, McNutt continued the
programme in the Anatomy Department at Galveston. Tips left for the University of
Oregon Medical School in Portland, where he developed a similar programme in coopera-
tion with a physician at the Oregon Fairview Home, George S Smith, after which both he
and Smith returned to Texas, to the Pediatrics Department at the Baylor Medical School in
Houston.15 Lynch himself moved to Nebraska, where he established a medical genetics
clinic at the University of Nebraska, College of Medicine. In 1964, Lynch took the ‘Short
12Lynch notes that he was invited to Creighton by
the medical school dean, Richard Egan. ‘Lynch
interview, 12th December 2003’, op. cit., note 9 above.
OnLynch’s appointment, seeWayneBLeadbetter, ‘Dr.
Lynch takes over’, The Beat, SMA, The Creighton
University, Nov. 1967, 1 (2): 1, 7; ‘Two new
department heads named’, Creighton Faculty
Newsletter, Nov. 1967: 3; John M McBride, ‘Boxing,
research in cancer both part of doctor’s career’, The
Creightonian, 27 Oct. 1967: 9; ‘Noted cancer
researcher heads medical department’, The
Creightonian, 17 Nov. 1967; ‘Named head at
Creighton’, Diagnosis News, March 1968, 1 (3): 24;
‘Authority on cancer genetics to head Creighton’s
preventive medicine unit’, West Omaha and Dundee
Sun, 2 Nov. 1967.
13Kenneth M Ludmerer, Genetics and American
society: a historical appraisal, Baltimore and London,
Johns Hopkins University Press, 1972, pp. 190–3. See
also Kevles, op. cit. note 10 above; Diane B Paul, The
politics of heredity: essays on eugenics, biomedicine,
and the nature–nurture debate, Albany, State
University of New York Press, 1998, pp. 133–56. For
British and Canadian perspectives, see, respectively,
Peter Coventry and John Pickstone, ‘From what and
why did genetics emerge as a medical specialism in the
1970s in the UK?’, Soc. Sci. Med., 1999, 49: 1227–38;
William Leeming, ‘Ideas about heredity, genetics, and
‘‘medical genetics’’ in Britain, 1900–1982’, Stud. Hist.
Phil. Biol. & Biomed., 2005, 36: 538–58; and William
Leeming, ‘The early history of medical genetics in
Canada’, Soc. Hist. Med., 2004, 17: 481–500. In
addition on human genetics, see Fortun and
Mendelsohn, op. cit., note 4 above.
14For details of this clinic, see the note in Robert L
Tips, George S Smith, Henry T Lynch and C Wallace
McNutt, ‘The ‘‘whole family’’ concept in clinical
genetics’, Am. J. Dis. Child., 1964, 107: 67–76, p. 67.
For a history of the University of Texas Medical
Branch, see Chester R Burns, Saving lives, training
caregivers, making discoveries: a centennial history of
the University of Texas Medical Branch at Galveston,
Austin, Texas State Historical Association, 2003.
15 In 1964, Tips listed his affiliation as Department
of Pediatrics, Baylor Medical School, Houston.
Table 1
Henry T Lynch’s appointments at Creighton University, 1967–1975.
1967–1968 Assistant Professor of Medicine, Creighton University
School of Medicine
1968–1970 Associate Professor and Chairman, Department of Preventive
Medicine, Creighton University School of Medicine
1970–present Professor and Chairman, Department of Preventive Medicine,
Creighton University School of Medicine
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Course in Medical Genetics’ organized annually since 1959 by Victor McKusick for the
National Science Foundation at Bar Harbor in Maine.16
Lynch’s vision of medical genetics revolved around what he called the ‘‘medical genet-
ics research team’’.17 In Nebraska, this team initially comprised Lynch himself, a social
worker, Anne Krush, some medical students, and consultants from the clinical and basic
science departments of the College of Medicine in Omaha and the College of Dentistry in
Lincoln, all supported by a network of referring physicians. Founded in 1961, the team
aimed to study the various hereditary diseases recorded in the state of Nebraska, and to
determine their geographic concentration through maps of incidences of these diseases.18
Lynch claimed that, with its predominantly rural population, Nebraska was ideally suited
for genetic investigations such as he proposed. Rural families, he noted, kept careful
records of their kindred, and often several generations of the family would live within
close proximity to each other, so facilitating researchers’ contacts with them. Lynch also
noted what he called ‘‘a deep-seated pioneering tradition and philosophy in support of
worthwhile pursuits’’19 among Nebraskans that made them particularly willing to help in
his investigations.
The cooperation of patients and their families was central to Lynch’s efforts to identify
genetic diseases. According to Lynch, patients and members of the family were first
interviewed by him for information on the major manifestations of the disease in the
patient and in other members of the family.20 They would be asked about marriage,
extramarital children and the possible presence of consanguity in ancestors. Lynch stated
that he would construct a family pedigree in collaboration with the patient, asking him or
her for information on marriage, paternities, surnames, maiden names, birth dates, preg-
nancy histories (with careful exploration for exposures to viral and bacterial infections,
drugs and other uterine environmental hazards) and manifestations of the disease in
relatives. Patients would be asked about the presence of other genetic diseases, and
about feuds and other intra-family conflicts to obviate future problems. Lynch stated
that he would review with the patient the objects of the investigation, questionnaires
that might be sent to other members of his or her family, and he would try to obtain
permissions forms.
16Lynch’s CV at <http://tobaccodocuments.org/
ctr/CTRMN011133-1160.html>, op. cit., note 9 above.
On the Bar Harbor course, see Ludmerer, op. cit., note
13 above, p. 191.
17H T Lynch, Anne Krush and Rose Faithe,
‘Medical genetics in Nebraska’, Nebr. State Med. J.,
1964, 49: 406–11. On the establishment of a genetics
clinic, see H T Lynch, ‘Heredity, cancer, and the
genetics clinic’, Texas Medicine, 1967, 63: 57–61.
18Among the sixteen types of diseases the team
studied were Dercum’s disease, transposition of the
great vessels, osteogenesis imperfecta, cystinosis,
dwarfism, diabetes, hypothyroidism, pulmonary
emphysema, and several (unspecified) forms of cancer.
19Lynch, Krush and Faithe, op. cit., note 17 above,
p. 411. Contrast this with the secrecy that McKusick
found a problem among the Amish. M Susan Lindee,
‘Provenance and the pedigree: VictorMcKusick’s field
work with the old order Amish’, in Alan H Goodman,
Deborah Heath and M Susan Lindee (eds), Genetic
nature/culture: anthropology and science between the
two-culture divide, Berkeley, University of California
Press, 2003, pp. 41–57. A revised version of Lindee’s
article onMcKusick has been published as chapter 3 of
her Moments of truth in genetic medicine, Baltimore,
Johns Hopkins University Press, 2005, pp. 58–89. On
the history of rural Nebraska families, see Deborah
Fink, Agrarian women: wives and mothers in rural
Nebraska, 1880–1940, Chapel Hill and London,
University of North Carolina Press, 1992.
20Lynch, Krush and Faithe, op. cit., note 17 above,
esp. p. 407.
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Anne Krush, Lynch’s social worker, was crucial to his efforts to secure the cooperation
of patients. Born on 27 June 1914 in Sewickley, Pennsylvania, Krush had graduated from
Wellesley College in 1936, before enrolling in the Western Reserve University School of
Medicine in Cleveland, one of only two women that year. After completing two years of
medical school, she transferred to the Western Reserve University School of Applied
Social Sciences, from where she graduated in 1941 with a Master of Science in Social
Administration. Her first job was as a medical social worker in Pittsburgh, after which she
moved to Massachusetts General Hospital in 1946, and then to Omaha, Nebraska. In 1961
she joined Lynch’s medical genetic research team as a research social worker in medical
genetics at the College ofMedicine. She accompanied Lynch to theMDAnderson Hospital
in Houston, where she held a position as a Research Associate in Medical Genetics,
returning (like Lynch) to Omaha in 1967 to become an Assistant Professor of Medicine
at Creighton University. As part of Lynch’s team, Krush would obtain information from
social agencies with which the family was involved; explore issues such as the emotional
response of family members to the ‘‘family disease’’; and investigate the needs of the
family for future agency or community welfare or rehabilitation.21
In the case of cancer, Lynch and Krush were particularly impressed at the knowledge
that these families had of the disease. Many family members, they noted, seemed extra-
ordinarily knowledgeable about the incidence and transmission of cancer in the family.22
These individuals, they claimed, were not knowledgeable of the general principles of
human genetics, yet they were able to make statements strongly implicating the likelihood
of hereditary factors, repeatedly referred to themselves as being part of a cancer family, and
so provided important clues for physicians to identify hereditary cancers. Not only did they
provide clues as to the identification of hereditary cancers, they also provided an oppor-
tunity to explore popular attitudes and feelings towards such diseases.23 Lynch and Krush
noted, for example, that the genealogical records kept by one family set the stage for much
internal family discussion about the ‘‘family disease’’, particularly among those indivi-
duals in the direct blood line who where approaching cancer risk ages. In the course of field
visits, Lynch and his colleagues used the offices of a private family physician to stage what
they called a ‘‘family reunion’’,24 which provided the opportunity for individuals not only
to comment on the ‘‘family tree’’ (or pedigree), but also for Lynch and his colleagues to
begin to study the responses of individuals towards cancer.25
21 Ibid. Biographical information on Krush is taken
from, ‘The Anne J. Krush Fund for Education and
Research in Hereditary Colorectal Cancer Syndromes’,
<http://hopkins-gi.nts.jhu.edu/pages/latin/giving/
annekrush.cfm> (accessed 17 April 2005).
22Anne J Krush, Henry T Lynch and Charles
Magnuson, ‘Attitudes toward cancer in a ‘‘cancer
family’’: implications for cancer detection,’ Am. J.
Med. Sci., 1965, 249: 432–8. One of the clues to the
identification of his first cancer family came from his
first CFS patient, who explained that he drank
excessively because he knew he would one day die of
cancer, like all members of his family. Henry T Lynch,
Thomas Smyrk, and Jane F Lynch, ‘Molecular genetics
and clinical-pathology features of hereditary
nonpolyposis colorectal carcinoma (Lynch syndrome):
historical journey from pedigree anecdote to molecular
genetic confirmation’, Oncology, 1998, 55: 103–8,
p. 104.
23Krush, Lynch and Magnuson, op. cit., note 22
above.
24 Ibid., p. 433.
25 Ibid., p. 434. See also the movie, The family tree.
Cancer genetics: guide to early diagnosis, University
of TexasMDAndersonHospital andTumor Institute at
Houston and the Richardson Foundation, produced by
Medical Communications, Houston, University of
Texas, 1967. Copy available in National Library of
Medicine (QZ 241 VC no.2 1967).
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If family members were important to the identification of genetic diseases, they were
also a problem. Individuals had faulty memories, and limited knowledge of the real nature
of disease. They did not know the secrets of other members of the family, and the records
they provided—bibles, photographs, diaries and so on—had limited value in identifying
specific diseases. As McKusick had found earlier, all this raised questions about the
reliability of knowledge produced from such sources.26 Thus, Lynch and Krush supple-
mented the interviews with evidence from other sources: medical records, historical
archives, libraries, census data, and the records of genealogical societies.27 They would
also supplement patients’ records and recollections with histological observations and
autopsy material. Lynch and Krush contrasted the certainty of the results achieved by
such a combination of interview and pathological observation favourably with pedigrees
based on unconfirmed reports and rumours—a characteristic, he claimed, of earlier human
genetics studies. Their approach was, they noted, ‘‘in keeping with modern medical
genetics research as opposed to earlier studies in human genetics where emphasis was
placed upon history alone with pedigree construction resting predominantly on hearsay
evidence.’’28 Lynch also contrasted it with what he called ‘‘bizarre misconceptions based
on folklore and old wives’ tales’’29 that families might harbour and offer as causes for the
occurrence of particular lesions. In such ways, Lynch and Krush sought to distance medical
genetics both from human genetics and from popular understandings of disease and
heredity.
Family Cancers
Lynch’s interest in cancer and heredity began shortly after his arrival in Omaha. He
recounts that in 1962 or 1964 Charles Magnuson, a gastroenterologist at the Omaha
Veterans Administration Hospital, requested that he consult on a patient with a strong
family history of colorectal cancer.30 Magnuson felt that familial adenomatous polyposis
(FAP) was most likely the problem in the family, since FAP was the only known hereditary
disorder predisposing to colorectal cancer.31 However, when Lynch and Krush drew up a
detailed pedigree, they found a strong predilection for colorectal cancer, but in the absence
of multiple colonic polyps. Lynch presented his findings at a meeting of the American
26Lindee, op. cit., note 19 above.
27Lynch’s interest in collecting such information
led him to criticize the common hospital practice of
destroying old medical records, see Henry T Lynch and
Anne J Krush, ‘The life and death of medical records’,
JAMA, 7 December 1970, 214: 1890.
28Lynch, Krush and Faithe, op. cit., note 17 above,
p. 410.
29Henry T Lynch, ‘Skin, heredity and cancer’,
Cancer, 1969, 24: 277–88, p. 286.
30Lynch, Smyrk, andLynch, op. cit., note 22 above;
Alan G Thorson, Joseph A Knezetic and Henry T
Lynch, ‘A century of progress in hereditary
nonpolyposis colorectal cancer (Lynch Syndrome)’,
Diseases of the Colon and Rectum, 1999, 42: 1–9.
Details of thework can be found in the ‘Family register’
compiled by Lynch for members of Family N. in 1978,
Papers held by Henry Lynch at the Creighton
University (hereafter Lynch archives). The register
states that the first patient was referred in 1964, the
others state 1962.
31On FAP, see Palladino, ‘Between knowledge and
practice’, op. cit., note 5 above. See also Palladino,
‘Speculations on cancer-free babies’ and Palladino,
Plants, patients and the historian, both op. cit., note 5
above.
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Society of Human Genetics in 1964. The story goes that his presentation reminded
Marjorie Shaw, a medical geneticist at the University of Michigan (Ann Arbor), of another
family with similar genetic and clinical manifestations. In 1966, she, Lynch, Krush,
Magnuson and Arthur L Larsen, a pathologist at the University of Nebraska Medical
Center, published their first report on the two families—family N from Nebraska, and
family M from Michigan.32 It was the beginning for Lynch of a long-standing interest in
what would come to be known as ‘‘cancer family syndrome’’ (CFS)33—now ‘‘hereditary
non-polyposis colorectal cancer’’ (HNPCC) or ‘‘Lynch’s syndrome’’.34
Lynch tells the story of the beginnings of his interest in CFS as one of happenstance. But,
if it happened by chance, it happened to someone who had already thought about hereditary
cancers and how they might be studied. In the 1950s and early 1960s, Lynch’s former
mentor in Austin, Clarence Oliver, was one of a small number of researchers that began to
explore the role of heredity in human cancers. Until then, the bulk evidence of such cancers
had come from experimental research on laboratory animals, especially mice.35 By con-
trast, Oliver and other geneticists turned to human populations to study the role of heredity
in a variety of cancers such as the breast, stomach, colon, and prostate, as well as the
leukaemias and lymphomas. Oliver, for example, used family studies to research the
hereditary contribution to risk of breast cancer, concluding that close relatives of breast
cancer patients had an increased risk of developing the disease, which he attributed to
shared genes.36 Thus, when Lynch identified his first case of a familial predilection
towards colorectal cancer in the absence of colonic polyps, he was building on a growing
number of family studies that explored the hereditary nature of the disease. Indeed, his
medical genetics research team was also identifying a number of other familial malig-
nancies in Nebraska, including cancers of the breast, stomach and prostate.37 It was
probably the work of this team that prompted Magnuson to turn to Lynch for help
with his colorectal patient.
32H T Lynch, M W Shaw, C W Magnuson, A L
Larsen, and A J Krush, ‘Hereditary factors in cancer:
study of two large midwestern kindreds’, Arch. Intern.
Med., 1966, 117: 206–12.
33 Ibid. Lynch described CFS as a pedigree
involving a high occurrence of adenocarcinomas of
multiple anatomical sites (most frequently in the
endometrium and colon), multiple primary malignant
neoplasms, an early age at onset, and autosomal
dominant inheritance. He contrasted this with familial
occurrences of malignancy, which by and large were
concerned with cancer of specific anatomic sites such
as the breast, stomach, prostate, and colon.
34The term ‘‘hereditary nonpolyposis colon
cancer’’ was used by Lynch in 1981. Henry T Lynch,
William Albano, James Recerbaren, Patrick M Lynch,
and Jane F Lynch, ‘Prolonged survival as a component
of a hereditary breast and nonpolyposis colon cancer’,
Medical Hypotheses, 1981, 7: 1201–9, p. 1202; H T
Lynch,G JVoorhees, S J Lanspa, P SMcGreevy and J F
Lynch, ‘Pancreatic carcinoma and hereditary
nonpolyposis colorectal cancer: a family study’, Br. J.
Cancer, 1985, 52: 271–3.
35On animal research and human genetics, see
Gaudilliere, ‘Circulating mice and viruses’, and
‘Making heredity inmice andmen’, both op. cit., note 4
above. But see Palladino for earlier studies of human
cancers, ‘Between knowledge and practice’, op. cit.,
note 5 above. See also Palladino, ‘Speculations on
cancer-free babies’, and Plants, patients and the
historian, op. cit., note 5 above.
36C P Oliver, ‘Studies on human cancer families’,
Ann. N. Y. Acad. Sci., 1958, 71: 1198–212; Clarence P
Oliver, ‘Genetic factors in breast cancer’, Proceedings
of the National Cancer Conference, 1964, 5: 133–42;
Clarence P Oliver, ‘Formal discussion of: cancer in
man’, Cancer Research, 1965, 25: 1327–29.
37Lynch, Krush and Faithe, op. cit., note 17 above.
This was his first published account in which he
indicated that cancer was one of the many hereditary
conditions he was studying that deserved more focused
attention.
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The idea that people might be hereditarily predisposed to cancer was not new. Nine-
teenth- and early-twentieth-century physicians routinely wrote about a predisposition
towards disease acquired through heredity, or through the insults to the body accumulated
over a lifetime, or through some combination of both.38 What was different about the
notion of heredity that Oliver, Lynch and other geneticists employed was—as Lynch
himself noted39—the use of statistics to identify the genetic nature of the predisposition.
In such studies, researchers would examine large populations affected with the disease,
analyse the ‘‘relative risks’’ for various factors such as sex or the number of family relatives
with the disease, and then draw conclusions about their roles in promoting cancer.40 The
link between heredity and cancer, therefore, tended to be expressed in terms of frequency
or probability. For example, Lynch characterized CFS as involving—among other fac-
tors—an increased frequency of adenocarcinomas, particularly adenocarcinomas of the
colon and endometrium, and an increased frequency of multiple primary malignant neo-
plasms. Individuals in cancer families, Lynch claimed, had a greater probability of suc-
cumbing to these cancers than the population at large, though they did not have a greater
probability of succumbing to other types of cancer. CFS was, therefore, probably a genetic
disease, he noted, and the genotype was probably specific to CFS.41
Lynch may have been persuaded that CFS was hereditary, but others were not. Critics
suggested that he had not taken adequate account of environmental or viral factors in his
studies of cancer families. Thus, in the late 1960s—as Lynch relates the story—an NIH
site-team expressed strong doubts about his claims for the genetic basis of CFS. In its view,
Lynch had not conclusively demonstrated that CFS families were the product of heredity:
they could be chance clusters of cancer, or due to common environmental exposures, or the
result of ascertainment bias. The site-team advised him to look for common environmental
factors in the rural families he studied.42 Others targeted his pathological work as
38For a discussion of proximate, remote,
predisposing and exciting causes, see Christopher
Hamlin, ‘Predisposing causes and public health in early
nineteenth-century medical thought’, Soc. Hist. Med.,
1992, 5: 43–70. Michael Worboys, Spreading germs:
disease theories and medical practice in Britain,
1865–1900, Cambridge and London, Cambridge
University Press, 2000. See also Robert Olby,
‘Mendelism and the theory of hereditary diathesis’,
Proceedings of the Symposium on the History of
Human Genetics, International Congress of Human
Heredity, Washington DC, 1991, published in K R
Dronamraju (ed.), The history and development of
human genetics, Singapore, World Scientific, 1992,
pp. 256–65; W F Bynum, ‘Darwin and the doctors:
evolution, diathesis, and germs in 19th-century
Britain’, Gesnerus, 1983, 40: 43–53.
39H T Lynch and A J Krush, ‘Heredity and breast
cancer: implications for cancer control’, Med. Times,
1966, 94: 599–605, p. 602.
40VElvingAnderson,HaroldOGoodman, Sheldon
C Reed, Variables related to human breast cancer,
Minneapolis, The University ofMinnesota Press, 1958.
For a history of the risk factor, seeWilliamGRothstein,
Public health and the risk factor: a history of an uneven
medical revolution, Rochester, NY, University of
Rochester Press, 2003.
41For a statement of such arguments in relation
to other hereditary cancers and that no genotype
seemed to lead to all cancers in general, see Curt Stern,
Principles of human genetics, 2nd ed., San Francisco
and London, Freeman, 1960, p. 566.
42Lynch, Smyrk, andLynch, op. cit., note 22 above.
I have been unable to find any records of this visit in
NIH or NCI records or archives. For a discussion of
statisticians’ attempts to eliminate bias in clinical trials,
see Harry M Marks, The progress of experiment:
science and therapeutic reform in the United States,
1900–1990, Cambridge University Press, 2997, esp.
pp. 144–6.
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problematic. Lynch recalls an incident at a European meeting when an unnamed43
gastrointestinal pathologist informed him that CFS families were simply FAP with
inadequate pathologic study. To Lynch’s embarrassment, the pathologist was proved
right in one case. One of the first alleged CFS families was later shown to have an
attenuated variant of FAP.44
In Lynch’s view, the attack on CFS was but one instance of a broader assault on studies
that pinpointed heredity as a significant cause of human cancers. Echoing the plaints of
many medical geneticists, he claimed that critics routinely sought to dismiss such studies
by suggesting that results were distorted by problems of data collection and analysis, as
when they pointed to issues of the adequacy of pathologic study or ascertainment bias.
They also sought to dismiss such studies by suggesting that their failure to find classical
Mendelian patterns of inheritance in all but a handful of cancers undermined claims for a
significant role for heredity. The major cancers of the breast, colon, stomach, endome-
trium, prostate and lung were often associated with an increase in risk to relatives of
individuals blighted by such diseases. Yet none exhibited a simple genetic inheritance
pattern, and so allowed for the possibility that other factors might be at work besides
heredity. Few critics would have suggested that heredity had no role in cancer; just that it
had no significant role.
Frustrated with his critics, Lynch was moved to label them so unsophisticated in medical
genetics as to ‘‘expect a definite [Mendelian] genetic pattern in human family histories, or
otherwise . . . discredit genetics as one factor in cancer development.’’45 (This claim of
unsophistication was made despite the fact that the NIH site team mentioned above
included what Lynch later called ‘‘distinguished’’ geneticists and epidemiologists.46)
Patterns of inheritance might be there awaiting discovery, he suggested, but the natural
history of the disease and methodological problems of human genetics got in the way of
discovery. For example, in the case of breast cancer he noted that the late stage of onset and
the lack of complete ascertainment of relatives could obscure the recognition of simple
genetic inheritance (a claim that may have confirmed his critics in their concerns that his
methods distorted his results.) Equally problematic, in Lynch’s view, was the possibility
that environmental and other extra-genetic factors might work against the discovery
of such patterns of inheritance. Quoting his former mentor, Clarence Oliver, Lynch
speculated that in the case of breast cancer the high frequency of solitary cases might
be due to the existence of two groups of causes of cancer, one hereditary, one environ-
mental. These patterns, he suggested, might be due to an inter-relationship between genes
43 In interview Lynch is very reluctant to name his
critics, and they seem to have been equally reluctant to
put their doubts about him into print. Lynch noted that
he did not wish to embarrass his former critics by
naming them. ‘Lynch interview, 12th December 2003’,
op. cit., note 9 above.
44Lynch, Smyrk, andLynch, op. cit., note 22 above,
p. 105.
45Lynch and Krush, op. cit., note 39 above,
pp. 600–601. Lynch’s comment was itself a quotation
from Oliver, ‘Formal discussion’, op. cit., note 36
above, p. 1327.Note thatOliver’s comment refers to lay
misunderstandings of genetics, while Lynch’s
comment can be read to refer to medical
misunderstandings.On the importance ofMendelism to
medical genetics, see Jean-Paul Gaudilliere,
‘Mendelism and medicine: controlling human
inheritance in local contexts, 1920–1960’, Comptes
Rendus de l’Acade´mie des Sciences. Se´rie III, Sciences
de la Vie, 2000, 323: 1117–26. Olby, op. cit., note 38
above.
46Lynch, Smyrk, andLynch, op. cit., note 22 above,
p. 104.
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and an unknown environmental agent in which the gene may be present but unexpressed
unless the proper environment coexisted.47
Such arguments, however, did not persuade his detractors, and Lynch found himself
preaching in a wilderness of doubt. Lynch argued that the impact of genetics on the body
and disease was always dependent on an interplay of genetics with environmental and
social factors. The genetic constitution of an individual was, he claimed, ‘‘an instrument
played upon by a variable environmental symphony’’,48 that included viruses, tobacco,
aniline dyes, coal tar, hydrocarbons, radiation, nitrogen mustards, and other carcinogens.
He also noted that national and ethnic differences such as occupations, industrial expo-
sures, food habits, climate, sexual customs, breast-feeding, and fecundity might be
Figure 2: Today, Henry Lynch is a leading figure in cancer genetics, his numerous papers presented
to packed conferences. This was not always the case. In the 1960s and 1970s, Lynch’s audiences
could be significantly smaller. Henry Lynch (left) and an unidentified individual at a poster session.
Undated photograph, probably late 1960s/early 1970s. (Henry Lynch archives. Reprinted with
permission of Henry Lynch.)
47Lynch and Krush, op. cit., note 39 above, p. 603.
The original comments are in Oliver, ‘Studies on
human cancer families’, op. cit., note 36 above. Then
again, in the case of CFS, the non-Mendelian character
of the segregation ratio in some sibships led Lynch to
suggest other factors at work besides autosomal
dominant inheritance, such as cytoplasmic inheritance
or virus factors or both. Lynch, Shaw, Magnuson,
Larsen, and Krush, op. cit., note 32 above. H T Lynch,
Henry M Lemon and Anne J Krush, ‘A note on
‘‘cancer-susceptible’’ and ‘‘cancer-resistant’’
genotypes’, Nebr. State Med. J., 1966, 51: 209–11.
48H T Lynch, P G Rigby, C W Magnuson, A L
Larson and A J Krush, ‘Etiology of carcinoma: genetic
determinism’,Nebr. StateMed. J., 1966, 51: 8–10, p. 9.
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important to the onset of cancer.49 But, disentangling the parts played by each member of
this symphony orchestra proved a difficult problem. It was quite unclear what was the
mode of inheritance, the role of heredity in promoting susceptibility or resistance to cancer,
or the relative contributions of heredity and environment.50 Lynch saw such problems as
mere obstructions to a better understanding of the role of heredity in cancer. The problem
for him was that his critics were not persuaded that heredity was a problem significant
enough to warrant such investigation; that they worried that Lynch’s methods of study
might have distorted his results; and that, perhaps, Lynch was himself predisposed to find
what he was looking for and so underestimated the significance of other explanations.
As such doubts persisted, Lynch came to believe that they had less to do with science and
more to do with the prejudice of major East-coast institutions against a small, mid-western
university that challenged the orthodoxy. He, therefore, threw himself back into his
research, accumulating more and more empirical data in the hope of changing minds,
and publishing the results in a wide range of (sometimes prestigious) journals.51 To this
end, he turned more and more to Nebraskan institutions and individuals for support.
Creighton University gave Lynch considerable freedom to continue his research.52 The
Omaha-based Eppley Institute funded some of his research when outside monies were hard
to get, as did the Nebraska ‘‘Aerie’’ of the Fraternal Order of Eagles.53 Nebraskan
physicians, Lynch noted, showed themselves enthusiastic about the project, making
medical records available, conducting laboratory and physical examinations for the
team, donating the use of their facilities and serving as liaisons between the team and
the families.54 And finally, Nebraskan families—and later families from other states—
welcomed him into their homes, and provided him with data crucial to his research. Critics
may have looked down on Nebraska, but Nebraska was to be the saving of Lynch.
Control and Delay
Lynch was interested not only in identifying hereditary cancers, but also in controlling
them. In his view, the identification of such cancers provided new opportunities for
49Lynch and Krush, op. cit., note 39 above, p. 603.
50 In his view, susceptibility and resistance worked
as a continuumwithin the population. At one end of the
continuumwere ‘‘cancer families’’ that had emerged by
‘‘selection’’ with an apparently strong hereditary
determinism to cancer. At the other end, were families
with little or no cancer, whichmight indicate hereditary
determinism against malignant neoplasia—
‘‘resistance’’ he called it, with inverted commas.
Lynch, Lemon and Krush, op. cit., note 47 above;
Lynch and Krush, op. cit., note 39 above.
51ManyofLynch’s publicationswere inNebraska’s
state medical journal. However, he also published in,
among other journals, JAMA, Cancer, and the Archives
of Internal Medicine. See other notes in this article.
Lynch may also have sought to bolster support by, for
instance, building allianceswith the insurance industry.
For example, in a 1971 paper he argued that the life
insurance industry should begin to take family histories
of cancer seriously in assessing risk. Henry T Lynch,
‘Genetic predictability in certain forms of cancer’,
Transactions of the Association of Life Insurance
Medical Directors of America, 1971, 55: 172–90.
52 ‘Lynch interview, 12th December 2003’, op. cit.,
note 9 above.
53On the history of fraternal societies, see David
Beito, From mutual aid to the welfare state: fraternal
societies and social services, 1890–1967, Chapel Hill,
University of North Carolina Press, 2000. Jason
Kaufman, For the common good? American civic life
and the golden age of fraternity, New York, Oxford
University Press, 2002. On the Nebraska branch or
‘‘aerie’’ of the Fraternal Order of Eagles, see its website
<http://www.foe.com/nebraska/> (accessed 18 July
2003).
54Lynch, Krush and Faithe, op. cit., note 17 above,
p. 411.
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recognizing the disease early in its development when it could be most effectively treated.
The detection of a hereditary cancer in one family member should, he suggested, prompt
greater vigilance for the possibility of cancer in others, otherwise ‘‘healthy’’. Yet, if Lynch
had hoped that members of cancer families would rush to their physicians at the first sign of
what might be the disease, he was often disappointed. Many seemed to avoid seeking help,
even if they suspected cancer and knew of relatives with the disease. Indeed, it seemed to
Lynch that the presence of cancer in the family might compound the problem. Familial
cancers were often regarded as a ‘‘disgrace’’,55 and individuals delayed not least because of
what they had seen it do to others. Thus, Lynch and Krush highlighted the case of one
patient—with a huge ulcerating carcinoma involving her entire left breast—who
explained: ‘‘Though my mother and two sisters had surgery for breast cancer, they
died in a horrible way . . . I decided to ignore mine as long as possible because there
is no hope.’’56
Lynch was not the first to note the problem of delay.57 Nor was he the first to suggest
hereditarian beliefs might compound the problem. For years cancer experts had argued that
the popular belief that cancer was hereditary worked against programmes of early detection
and treatment by dissuading people from seeking help. Such a belief, they claimed,
encouraged fatalism among those who had relatives with cancer, and complacency
among those who did not. If heredity did contribute to cancer, they suggested, it contributed
such a small amount, that any mention of it might do more damage than good. Conse-
quently, most cancer education programmes invested huge efforts in educating the public
in the belief that cancer was not a hereditary disease.58 It was, from their perspective, often
better to deny bluntly that heredity contributed to cancer, than to risk perpetuating popular
misconceptions about it by highlighting its limited role in promoting the disease.59 Such
55Anne J Krush, ‘Heredity, emotions, and
carcinoma: delay in cancer detection’, in Henry T
Lynch, Hereditary factors in carcinoma, New York,
Springer, 1967, 141–53, p. 146.
56Lynch and Krush, op. cit., note 39 above, p. 603.
For another example of a patient delaying after
witnessing the effect of cancer in another family
member, see H T Lynch, T P Krush and Anne Krush,
‘Psychodynamics in cancer detection: a patient
with advanced cancer of the lip’, Psychosomatics,
1966, 7: 152–7.
57Aronowitz, op. cit., note 1 above.
58See, for example, the dismissal of hereditarian
explanations of cancer in the following ACS movies:
The traitor within, John Sutherland Productions, 1946;
and Man alive, produced by UPA, United Productions
of America, 1952, both presented by the American
Cancer Society. Copies of both are available in the
National Library of Medicine. For early critiques of
hereditarian explanations, see ‘A war department
lecture on cancer’, Campaign Notes. American Society
for the Control of Cancer, September 1918, 1 (6):
[pp. 2–3]. This does not deny that heredity may play a
role, but suggests it is only a small factor in the onset of
disease. For this reason, it claims that it is not a
hereditary disease. George R White, ‘The control of
cancer’, Campaign Notes. American Society for the
Control of Cancer, October 1918, 1 (7): [pp. 2–3];
FrancisCarterWood, ‘What everywoman should know
about cancer’, Campaign Notes. American Society for
the Control of Cancer, January 1919, 1 (9): [pp. 1–4];
Eugene Lyman Fisk, ‘A deadly foe routed’, Campaign
Notes. American Society for the Control of Cancer,
February, 1919 1 (10): [pp. 1–4].
59This is not to say that cancer education always
ignored the subject of heredity. Some educational
pamphlets highlighted animal experiments that
suggested a hereditarian component to cancer, only to
raise questions about the applicability of such
experiments to human cancer. See, for example, Lester
Grant, The challenge of cancer: a research story that
involves the secret of life itself, Bethesda MD, Federal
Security Agency, Public Health Service, National
Institutes of Health, 1950; Clarence C Little, The fight
on cancer, NewYork, Public Affairs Committee, 1939,
p. 18; and Dallas Johnson for the American Cancer
Society and the National Cancer Institute, Facing the
facts about cancer, New York, Public Affairs
Committee, 1947, pp. 21–3. See also C C Little,
‘Research’, in Clarence C Little (ed.), Cancer: a study
for laymen, New York and Toronto, Farrar & Rinehart,
1944, pp. 3–46, on pp. 43–4.
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attitudes—combined with doubts about Lynch’s claim to have identified hereditary
cancers—were to prove a major problem for his efforts to promote heredity as a
means of improving cancer control. The fact that he himself found that would-be patients
delayed because of the stigma and fears generated by familial cancers did not help his case.
Lynch’s answer to this quandary focused on devising means of tackling emotional and
psychological responses to hereditary cancers (in addition, that is, to his continued efforts
to persuade his colleagues of the importance of heredity to human cancer). In his view, such
responses were often neglected. Physicians knew little about their patients, still less about
their families; education programmes were aimed at the mass rather than the individual;
and genetic counselling addressed only the facts of heredity rather than psychological and
emotional reactions to the identification of a genetic condition in the family. All this left
would-be patients and their families confused, and failed to address the complex factors
that promoted delay. It was all too easy, Lynch argued, for control measures to be under-
mined by the tides of fear, denial, evasion, guilt and apathy that he detected in patients and
their families during his field investigations.60 Only by a detailed personal knowledge of
patients and their families would it be possible to channel individuals to appropriate
specialist care; to ensure that they got such care in a timely manner; and that they continued
with care during what could be a long, painful and uncertain course of treatment.
Thus, Lynch envisaged a state-wide network of cancer clinics and hospitals; supported
by ancillary laboratory, registry and diagnostic facilities; linked by a referral system that
passed sick or at-risk patients to appropriate specialist help; and all sustained by public
education programmes that encouraged people to seek help.61 At the heart of this system
was to be the family physician, the gateway to the rest of the network.62 In Lynch’s view,
the family physician was the physician most likely to be aware of cancer in the family; best
placed to spot the sometimes subtle early warning signs of the disease; and, as a trusted
AsKarenRader notes, CCLittle, head of theASCC
and the Jackson Memorial Laboratory, promoted
animal genetic research in his popular publications
from the 1930s, but was cautious in applying this work
to humans. Anxious that an emphasis on familial
cancers might discourage efforts to promote cancer
control, Little urged people with cancer in the family to
be alert, cautious and intelligent in detecting and
reporting cancers, and not to worry. (Rader, op. cit.,
note 4 above, pp. 194–6.) Such caution is well
illustrated by the two pamphlets (above) Little
published in 1939 and 1947, the second a revised
version of the 1939 pamphlet by Dallas Johnson, an
NCI publicity official. Both these pamphlets included
accounts of animal experimentation and heredity. But
both also included the following caption prominently
displayed on the cover: ‘‘Did you know: That cancer is
NOT hereditary or contagious?’’ The text inside the
1939 edition warned readers that while a tendency to
form cancer might be inherited in humans, it was so
indirect that there need not be a source of worry to
anyone (p. 18). The discussion inside the 1947 edition
was perhaps more cautious about the applicability of
mouse experiments to humans.Unlike the 1939 edition,
it contained nowarnings to people not toworry if cancer
in the family was discovered, and the section on
heredity (p. 21) concluded with a discussion of mouse
experiments that suggested that a virus in the mother’s
milk might be the cause of cancer. On virus research,
see Angela N H Creager and Jean-Paul Gaudilliere,
‘Experimental platforms and technologies of
visualisation: cancer as viral epidemic’, in Gaudilliere
and Lo¨wy (eds), Heredity and infection, op. cit., note 4
above, pp. 203–41; and Gaudilliere, ‘Circulating mice
and viruses’, op. cit., note 4 above.
60For Lynch and Krush’s discussions of emotive
responses to cancer, see Krush, Lynch and Magnuson,
op. cit., note 22 above; Lynch and Krush, op. cit., note
39 above; Krush, op. cit., note 55 above.
61On the creation of such referral systems, see
David Cantor, ‘Cancer’, in Dominique Lecourt,
Franc¸ois Delaporte, Patrice Pinell, Christiane Sinding
(eds), Dictionnaire de la pense´e me´dicale, Paris,
Presses Universitaires de France, 2004, pp. 195–201.
62See, for example, the movie Lynch released in
1967 (during his time in Houston) designed to educate
family physicians about hereditary cancers and their
role in detecting it. The family tree, op. cit., note 25
above.
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family friend, the best candidate to persuade people to undergo regular screening, to direct
them to appropriate specialists if cancer was discovered, and to convince them to stay the
course of treatment when the going got tough. His vision was of a network of such
physicians across the state (and the country) monitoring (cancer) families, and feeding
those affected by the disease to specialist centres where they could get suitable care.63
Lynch argued that physicians should ‘‘assume the role of both teacher and partner’’64 to
their patients. They would correct misconceptions about the disease and heredity; encou-
rage people to seek regular detection examinations; and combat the irrational fears that
many individuals had of the disease and heredity. He was particularly hopeful of cancer
education at the grade school or early high school level, when the student first encountered
science and biology. Teaching students the facts about cancer, he believed, could serve as a
platform from which to combat the fear associated with learning about cancer later in
adulthood, especially if the early cancer education emphasized the positive aspects of
cancer control through early diagnosis. Accordingly, Lynch’s department launched a
programme in which junior and senior medical students visited local schools to discuss
the biological aspects of cancer and its social ramifications.65
But physicians could do only so much. Building on his experience in Galveston—where
he, Tips, Smith, and McNutt had developed a model of ‘‘whole family’’ or ‘‘family
centered’’ genetic counselling66—Lynch argued the case for clinically-trained genetic
counsellors to address the problems of hereditary cancer.67 In an increasingly specialized
and fractured health care system, such a genetic counsellor would, ideally, be someone able
to mediate all the information given to patients and their families; provide a more nuanced
communication of the nature of disease and heredity; address the families’ emotional
responses to these efforts; and elicit better information on other family members who
might be at risk. Moreover, if the counsellor was also the cancer specialist, he or she could
bring together the various medical and social services that the patient and his or her family
would need to deal successfully with the problem. Thus, Lynch promoted an ‘‘integrative
63Thus, he instituted a programme to introduce
medical students to the reality of disease as it affected
people in their homes, and so to encourage empathy
with patients. Henry TLynch, Anne J Krush and Joseph
MHolthaus, ‘Teaching comprehensive medicine in the
home setting: a preliminary report’,Nebr. StateMed. J.,
1969, 54: 454–7, 516–18.
64Henry T Lynch and Anne J Krush, ‘Early cancer
detection is not just the patient’s problem’, Consultant,
1971, 11 (4): 58–60, p. 59.
65Henry T Lynch, ‘A note on cancer control’,Nebr.
State Med. J., 1971, 56: 99–100; Lynch and Krush,
op. cit., note 64 above.
66Tips, Smith, Lynch and McNutt, op. cit., note 14
above; Robert L Tips and Henry T Lynch, ‘The impact
of genetic counseling upon the family milieu’, JAMA,
20 April 1963, 184: 183–6; R L Tips, Henry T Lynch
and C Wallace McNutt, ‘Genetic counseling’, Texas
State Journal of Medicine, 1964, 60: 650–3; Henry T
Lynch, Robert L Tips, Anne Krush and Charles
Magnuson, ‘Family centered genetic counseling:
role of the physician and the medical genetics clinic’,
Nebr. State Med. J., 1965, 50: 155–9; H T Lynch, T P
Krush, A J Krush and R L Tips, ‘Psychodynamics of
early hereditary deaths. Role of the medical genetics
counselor’, Am. J. Dis. Child., 1964, 108: 605–10. See
also R L Tips, ‘Dynamics of genetic counseling’,
Eugenics Quarterly, 1962, 9: 237–40; Robert L Tips,
George Smith and Donald L Meyer, ‘Reproductive
failure in families of patients with idiopathic
developmental retardation’, Pediatrics, 1964, 33:
100–105.
67Henry T Lynch, ‘Cancer and genetic counseling’,
in Lynch, Hereditary factors in carcinoma, op. cit.,
note 55 above, pp. 154–68. On the dominance of
physicians in genetic counselling during this period, see
Regina H Kenen, ‘Genetic counseling: the
development of a new interdisciplinary occupational
field’, Soc. Sci. Med., 1984, 18: 541–9. See also
Ludmerer, op. cit., note 13 above, pp. 174–93.
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psychologic approach’’ to counselling, providing what he called total medical and
psychosocial evaluation and support to a patient and his or her family.68 Given contem-
porary moves in the Nebraska of the late 1960s and early 1970s to promote screening for
other genetic conditions there may have been optimism that such a scheme could have been
instituted.69
Problems
The rudiments of a system of cancer control had existed in Nebraska since the early
1920s.70 But, until Lynch arrived in the state, cancer experts had tended to see hereditarian
beliefs as a hindrance to cancer control rather than a help. Part of the problem has already
been mentioned: hereditarian beliefs, experts suggested, tended to promote delay, and
consequently Nebraskan cancer programmes, like those elsewhere, tended to educate the
public in the belief that cancer was not a hereditary disease. But, hereditarian beliefs also
raised another problem. Experts worried that they prompted eugenic concerns that cancer
control might increase the hereditary burden of cancer, and so might weaken medical and
state support for anti-cancer efforts. Thus, for example, in 1939 an editorial in the state
medical journal reassured its readers that early cancer detection and treatment would
‘‘more than offset such handicaps as heredity may impose’’.71 By the 1960s, concerns
about negative impact of eugenics on cancer control appear to have dissipated; commen-
tators suggested that eugenics was no longer a popular concern.72 But for Lynch a new set
of problems had emerged.
As relations between eugenics and genetics were reconfigured after the Second World
War, attention began to shift towards what Sheldon C Reed, Director of the Dight Institute
for Human Genetics, called ‘‘non-directive genetic counseling’’. In non-directive counsel-
ling, the genetic counsellor was little more than a purveyor of technical—‘‘value-free’’—
information on heredity. Reed suggested that the decision of what to do with this informa-
tion be left to the family rather than to state or other agencies.73 Lynch was dismayed by
such suggestions. Describing Reed’s approach as ‘‘cold, mathematical, and stereo-
typed’’,74 he claimed it neither fully characterized the manifold needs of a family with
a genetic condition, nor provided insight into how to counsel such families effectively.
68On integrative psychological support, see Henry
T Lynch, Dynamic genetic counseling for clinicians,
Springfield, IL, Charles C Thomas, 1969, esp. ch. 2.
69Philip Reilly, ‘State supported mass genetic
screening programs’, in AubreyMilunsky andGeorge J
Annas (eds), Genetics and the law, New York and
London, Plenum Press, 1976, pp. 159–94.
70P F, ‘Cancer week’, Nebr. State Med. J., 1921,
6: 290–1; P F, ‘Cancer week’, Nebr. State Med. J.,
1921, 6: 324–5; Palmer Findley, ‘The cancer
problem’, Nebr. State Med. J., 1922, 7: 384–5; ‘The
1923 cancer campaign’, Nebr. State Med. J., 1923, 8:
412. On the status of cancer control in Nebraska in
the 1930s, see Frank Leslie Rector and Clarence
Cook Little, ‘Report of a cancer survey of
Nebraska’, Nebr. State Med. J., 1935, 20:
409–42.
71 ‘Progress in the control of cancer’, Nebr. State
Med. J., 1939, 24: 138–9, p. 139.
72 John Baldwin, ‘History of the eugenic
movement’, Nebr. State Med. J., 1962, 47: 458–65.
73Sheldon R Reed,Counseling in medical genetics,
Philadelphia, Saunders, 1955, pp. 14–15. On Reed and
the Dight Institute for Human Genetics, see Paul, op.
cit., note 13 above, pp. 133–56. See also
Molly Ladd-Taylor, ‘ ‘‘A kind of genetic social work’’:
Sheldon Reed and the origins of genetic counselling’,
inGeorginaDFeldberg,Molly Ladd-Taylor, Alison Li,
and Kathryn McPherson (eds), Women, health and
nation: Canada and the United States since 1945,
Montreal, McGill-Queen’s University Press, 2003,
pp. 67–83.
74Lynch, op. cit., note 67 above, p. 154.
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Moreover, Lynch noted, the problems of cancer were very different to those of many other
genetic diseases. The principle concern in the case of cancer was not the question of
reproductive choice: the real problem was to persuade family members at risk to seek help,
and to seek it early. Yet all too often, he argued, individuals seemed to work against their
own best interests, risking their own lives by delaying seeking medical attention. In such
circumstances, it was insufficient to limit genetic counselling to the transmission of
technical information on heredity. The physician had to do more.
For such reasons, Lynch abandoned many of the tenets of non-directive counselling. In
his view, the lay public was vulnerable to powerful, even overwhelming (psychodynamic)
forces that limited their ability to make rational choices. It followed that physicians were
compelled to take greater responsibility for ensuring that they sought help early, and stayed
the course of treatment.75 It was a medical responsibility to ensure that the cancer control
message got through. This is not to say that Lynch argued that patients had no respon-
sibility: indeed, he complained that education programmes were ‘‘noticeably weak in
emphasizing clearly that it is the patient who must undertake responsibility for his
own physical welfare’’.76 Nevertheless, he generally subordinated such arguments to a
view of patients and the public as subject to often irresistible forces that limited their
capacity to take such responsibility. Such limitations necessitated the active intervention of
a physician or counsellor to address the issues that encouraged delay.77
Yet almost from the start his scheme encountered difficulties. In the first place, his
efforts to address the problem of patients’ responses to the diagnosis of a hereditary
condition did little to quash medical fears that hereditary conditions might encourage
delay and prompt fear. The point was brought home to Lynch in 1977 when critics attacked
his call for a national registry system of cancer families to identify patients at risk of the
disease, and to help in the estimation of risk for particular target organs. Richard Gatti
(Director of the Division of Pediatric Oncology and Immunology at the Cedars-Sinai
Medical Center, Los Angeles) argued that such a diagnosis could leave patients quite
fearful of the disease. The fact that some in a cancer family who underwent screening did
not have cancer was hardly reassuring, since it only opened up the possibility that they
might get it in the future. Gatti proposed that further family studies be abandoned until a
genetic test was available that could give more certain prognoses. Lynch did himself no
favours by responding to Gatti that his experience in Nebraska could act as a model for
work elsewhere. As the Harvard paediatrician and human geneticist, Park S Gerald, put it:
‘‘what is acceptable in Nebraska may not be acceptable in other parts of the country’’.78
Even in Nebraska things did not go as smoothly as Lynch might have wished. Responses
to a cancer screening van that he organized in the late 1960s and early 1970s indicate the
nature of the problem. ‘‘We went around the country, Michigan, all over the place,’’ Lynch
75Lynch and Krush, op. cit., note 64 above.
76Krush, Lynch and Magnuson, op. cit., note 22
above, p. 437.
77The importance of physician (and family)
intervention to Lynch is well illustrated by his
account of one of his early cancer patients, an unnamed
farmer-cum-mill worker who came to him and his team
around 1965. Lynch, Krush and Krush, op. cit., note 56
above.
78Comments in Henry T Lynch, Jane Lynch and
Patrick Lynch, ‘Management and control of familial
cancer’, in John J Mulvihill, Robert W Miller and
Joseph F Fraumeni Jr (eds), Genetics of human
cancer, progress in cancer research and therapy,
volume 3, New York, Raven Press, 1977,
pp. 235–56, on p. 255.
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recalls, ‘‘screening people for cancer. We did pelvic, breast, mouth exams for free. We
gave advice to keep healthy, and it was all run by volunteers, by the community.’’79
Suddenly, however, the state funds for the project dried up. According to Lynch, a
group of Nebraskan physicians persuaded a state representative to kill the project. ‘‘It
was just greed on the part of these doctors because we were providing a free service and
they were getting paid for it before,’’ Lynch remembers. ‘‘I had just finished doing an exam
on this woman and she thanks me and says, ‘Thank you, doctor. You know, my doctor says
you are a communist, but you don’t look like a communist!’ ’’80
More generally, Lynch also came to have doubts about the ability of family physicians to
tackle the disease. Despite his hopes that the family physician would channel patients to
appropriate care, he complained that they were often ignorant of the disease, overly
pessimistic about the possibility of successful treatment, and unwilling to send patients
to trained genetic counsellors—so dissuading many would-be patients from seeking or
continuing care. How rarely, he felt, they seemed to see the problems of delay and non-
compliance as problems requiring active medical intervention—and perhaps in part for
practical reasons as much as ignorance. With family physicians increasingly thin on the
ground in the 1960s and 1970s,81 Lynch and his colleagues complained that low physician-
to-patient ratios did not allow sufficient time for the average family physician to practise
adequate preventive medicine—including early detection.82 In their view, patients were
increasingly being left in the dubious hands of the specialist. The fear was that specialists
often knew too little about the patient and his or her circumstances; that patients were
unable to form close personal relations with them; and that they—the patients—conse-
quently became confused and unable to appreciate fully what was being done for them,
sometimes with dire psychological and therapeutic consequences.
To add to these difficulties, Lynch complained that there remained a disturbing ignor-
ance of the psychology of hereditary disease among many physicians, who (inadvertently,
perhaps) encouraged fear and despair in their patients by seeking to identify those respon-
sible for the hereditary condition. ‘‘This writer and his medical genetic colleagues’’, Lynch
wrote in 1967, ‘‘have all too frequently observed the scars and despair of patients who have
consulted and been advised by untrained individuals so that they might ‘clear up this family
problem and find out who really is to blame for the hereditary factor’.’’83 Such basic errors
of counselling were compounded, he felt, by the Reedian perception of genetic counselling
as education in the facts of genetic transmission. Such facts, Lynch argued, might be
important to the physician or counsellor, yet they were usually of relatively minor impor-
tance to the patient. Patients, he claimed, were more concerned with the emotional
79H T Lynch interview with Raul Necochea 7 July
2003, Raul Necochea, report 2, additional or enriched
issues in HTL’s works based onmore recently obtained
literature, on literature that links the work of HTL and
that of other researchers, on Raul Necochea’s field
notes from his first trip to Omaha, and on his first
interview with HTL July 2003.
80 Ibid.
81Rosemary A Stevens, ‘The Americanization of
family medicine: contradictions, challenges, and
change, 1969–2000’, Family Medicine, 2001, 33:
232–43.
82Michael J Haller (Director of the Family Practice
Section of Lynch’sDepartment of PreventiveMedicine
andPublicHealth), ‘The role of the family physicians in
the diagnosis and treatment of cancer’, in Henry T
Lynch (ed.),Cancer and you, Springfield, IL, CharlesC
Thomas, 1971, 216–25.
83Lynch, ‘Cancer and genetic counseling’, op. cit.,
note 67 above, p. 157.
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ramifications and physical consequences of a particular disorder than with formal genetic
interpretation.84
Families
It should be clear by now that the family was central to Lynch’s vision of cancer control,
and in two distinct ways. First, Lynch’s approach to cancer control involved an
understanding of the family as a hereditary or genetic entity in which certain cancers
or pre-cancerous conditions (or predispositions towards such cancers or pre-cancerous
conditions) passed from one generation to another, the actual occurrence of cancer being
the product of specific (albeit unknown) conjunctions of environmental and genetic
factors, and predicted by means of statistical probabilities derived from family studies.
From such a perspective, Lynch argued that the identification of a hereditary cancer in one
member of a family should, ideally, be followed both by attempts to persuade that indi-
vidual to seek early treatment, and by the surveillance of healthy members of his or her
family so as to increase opportunities for spotting the disease at a stage in its development
most amenable to treatment.
Second, Lynch’s approach to cancer control involved an understanding of the family as a
psychosocial entity, easily disturbed by the disease, the diagnosis, or the interventions
against it. In Lynch’s view, the diagnosis of a hereditary cancer often generated complex
and sometimes conflicting responses that had to be understood in the context of the beliefs,
attitudes and patterns of emotional and mental interaction specific to individual families.
People delayed seeking medical attention, abandoned promising therapies, turned to
‘‘quacks’’, and risked economic ruin or a wrecked marriage rather than seek assistance.
They also developed strange and disturbing behaviours, such as that of the man who forced
his children to kiss him full on his tumorous lip:85 behaviours that deeply upset other family
members and so exacerbated psychological and social problems related to the disease.
All these self-destructive problems could be explained, at least in part, by reference to
the family circumstance. ‘‘Genetic problems are family problems,’’ Lynch wrote, ‘‘and are
often steeped with anxiety, guilt, fear, hostility, apprehension, ambivalence and miscon-
ceptions.’’86
The family was thus a double threat to its individual members, and hence to efforts to
promote cancer control. In Lynch’s view, it was not only a carrier of hereditary disease. It
was also the carrier of beliefs, attitudes and patterns of emotional and mental interaction
that shaped—consciously or unconsciously—individual responses to the disease. Deborah
Weinstein has shown that post-war family therapists increasingly saw mental illness as
rooted in patterns of family interactions rather than the biological or psychological
84 Ibid., pp. 165–6.
85Lynch, Krush and Krush, op. cit., note 56 above.
The children in this case were repulsed by the sight and
touch of the massive lip lesion, and became fearful
and anxious.
86Lynch, op. cit., note 67 above pp. 155–6.
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characteristics of the individual.87 Lynch saw similar roots to the many psychological and
social problems that followed the diagnosis of hereditary cancer. In his view, it followed
that it was impossible to treat the hereditary disease without addressing the family
situation.
The problem for Lynch was that cancer control programmes rarely tackled such situa-
tions. They failed to view the family as a carrier of hereditary cancers, and so failed to
target family members at risk of the disease. They also failed to view the family as a
psychosocial entity, and so failed to target familial difficulties that promoted delay, non-
compliance, or disruptive behaviours. In consequence, Lynch argued these programmes
contributed to what he called physician delay—the failure of physicians to recognize the
seriousness of the problem—as important an issue as patient delay, he claimed.88 In
Lynch’s view, control programmes needed to educate physicians about their own con-
tributions to delay and other problems, and, indeed, to begin to take a much more inter-
ventionist approach to cancer control. As noted earlier, he argued that it was not sufficient
to place responsibility solely on the patient to seek medical assistance: people were easily
overwhelmed by the cancer or their family’s response to it. Physicians had a responsibility
to help them overcome mental and emotional barriers to care. They also had a respon-
sibility to help them overcome the social, racial, ethnic, occupational and socio-economic
factors that promoted delay and non-compliance.89 Such responsibilities should, in
Lynch’s view, be part of any programme of cancer control.
In his efforts to promote such medical responsibilities, Lynch turned for inspiration to an
imagined older world of medicine, untainted by the increasing tendency he detected of
physicians to limit their own responsibilities and so abandon patients to their own
resources.90 His image of the family physician as friend and confidant to the family
harkened back to a mythic golden age of family practice now sadly almost gone. In
this imagined era, physicians, patients and families were bound together in complex,
long-term, evolving sets of relationships that made it quite impossible for physicians to
treat only the disease. Physicians brought their patients into the world, treated their child-
hood ailments, and saw them develop through adolescence, and into adulthood and old age.
They treated their parents, siblings, spouses and children. They were physicians to the
family as much as the individual patient, important figures in the local community, well-
placed to address the complex familial and social issues that illness could create. These
were the foundations upon which Lynch hoped to build a new programme of cancer
87Deborah F Weinstein, ‘Culture at work: family
therapy and the culture concept in post-World War II
America’, J. Hist. Behav. Sci., 2004, 40: 23–46;
Deborah Fran Weinstein, ‘The pathological family: a
cultural history of family therapy in post-World War II
America’, PhD thesis, Harvard University, 2002.
88Henry T Lynch and Anne J Krush, ‘Attitudes and
delay in cancer detection’, CA: Cancer Journal for
Clinicians, 1968, 18: 287–93.
89For example, he speculated that the western
tradition of independence and self-reliance among the
white Nebraskan rural population encouraged
excessive feelings and beliefs of self-sufficiency. All
too often, he noted, Nebraskans used their own
resources to defray the costs of illness, even to the point
of destitution. Traditions of self-reliance, he noted,
contributed to a lack of knowledge of the resources
available through state, federal and community
agencies. Krush, Lynch andMagnuson, op. cit., note 22
above, p. 436.
90There are strong parallels between Lynch’s
critique of narrow specialization and that of early
twentieth-century holists, see Christopher Lawrence
andGeorgeWeisz (eds),Greater than the parts: holism
in biomedicine, 1920–1950, New York and Oxford,
Oxford University Press, 1998.
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control, reinforced by the newer insights of medical genetics, ‘‘whole family therapy’’ and
‘‘integrative psychologic approaches’’ to counselling. Control, in Lynch’s imagination,
involved a return to an older set of community values, in which family physicians took
greater responsibility for their patients’ welfare, watched them for signs of ill-health, and
intervened as only a trusted friend could when things seemed awry. Here was a vision of
‘‘surveillance medicine’’91 built on the social relations, medical practices, and ethics of an
imagined earlier age.
The family physician was thus the symbolic moral core of the cancer control system
that Lynch hoped to develop; a figure who blended the values of an older world of
medicine, with those of modern science. Lynch would have been the first to admit that
in practice physicians often did not meet such lofty values. Rather, the figure of the
family physician served to help construct a model of care and responsibility to which
cancer control programmes (and physicians within them) could aspire. In such
programmes, the family physician was, as we have already noted, to be a gatekeeper
to the cancer control system. But, he or she was also to be its ethical heart, someone
who not only referred patients to others within the system, but whose values and
approach permeated practice across the system. Cancer specialists, medical geneticists,
and genetic counsellors all had to adopt something of the approach of the family physician.
They had to know their patients and their families in all their complexity, and to take more
of the responsibility for helping them seek medical assistance, and stay the course of
treatment.
Indeed, at one point Lynch argued that because of an acute shortage of professionally
trained genetic counsellors, family physicians should assumemuch of the responsibility for
counselling.92 In his view, the practice of genetic counselling had many parallels with the
work of the family physician. It involved the traditional physician–patient relationship of
‘‘intimacy and confidence’’.93 Ideally, it sought to address the mental and emotional sides
of illness, as much as it addressed the biological side. It was less a science than an art. It
involved the acquisition of a broad, intimate knowledge of the patient and his or her
circumstances; an incommunicable knowledge, something ‘‘one could not possibly
hope to describe . . . in words’’.94 In genetic counselling, as in family medicine, nothing
substituted for the ineffable experience of working face-to-face with patients.95 It will
91On surveillance medicine, see David Armstrong,
‘The rise of surveillance medicine’, Sociology of
Health and Illness, 1995, 17: 393–404.
92Henry T Lynch, Gabriel MMulcahy, and Anne J
Krush, ‘Genetic counseling and the physician’, JAMA,
1970, 211: 647–51, p. 651. On Lynch’s view of the role
of the physician in genetic counselling, see also Henry
T Lynch and Anne J Krush, ‘Genetic counseling and
cancer: implications for cancer control’, Southern
Medical Journal, 1968, 61: 265–9; Henry T Lynch,
Gabriel M Mulcahy, and Anne J Krush, ‘Genetic
counseling (A scientific exhibit)’, Nebr. State Med. J.,
1970, 55: 209–16. Regina Kenen has noted that genetic
counselling in the 1950s and 1960s was dominated by
physician practitioners: Lynch vigorously argued that
this was a desirable state of affairs. Kenen, op. cit., note
67 above.
93Lynch, op. cit., note 67 above p. 155.
94 Ibid.
95On clinical attitudes to language in the British
context, see David Cantor, ‘The NAME and the
WORD: Neo-Hippocratism and language in inter-war
Britain’, in David Cantor (ed.), Reinventing
Hippocrates, Aldershot, Ashgate, 2001, pp. 280–301;
Christopher Lawrence, ‘Incommunicable
knowledge: science, technology and the clinical art
in Britain 1850–1914’, J. Contemp. Hist., 1985, 20:
503–20.
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be recalled that Lynch also suggested that the cancer specialist should assume
responsibility for counselling. But in Lynch’s vision of cancer control, this was a specialist
who shared many of the values of the family physician. Distinguished by his or
her greater knowledge of the disease and its management, this imagined specialist
(like the family physician) sought to integrate the medical, social and psychological
care of the patient and his or her family. How different this was to the current world
of cancer control, where physicians rarely knew their patients well, let alone their families,
and so failed to understand or address their emotional and mental responses to hereditary
cancers.
Yet it was an uphill struggle to promote this approach to cancer control. The
methods Lynch proposed to identify familial pathologies were undermined by the
problems of family medicine; by the enthusiasm for ‘‘non-directive’’ counselling; by
doubts about the significance of heredity to human cancers; by the contemporary
enthusiasm for viral and environmental explanations for cancer; and, perhaps, by a
reluctance on the part of many physicians to take the level of responsibility that Lynch
advocated for ensuring that their patients did not delay. Nor were Lynch’s proposals helped
by his own location in a minor educational institution, in (to the eyes of the cancer
establishment) a remote part of the country. In the 1960s and 1970s, Lynch was simply
unable to persuade most physicians and geneticists that he had identified a significant
hereditary component to human cancer, or that this might provide the basis of a new
approach to cancer control.
Lynch’s marginal position would not begin to change until the identification of the
first cancer genes in the 1990s, when his collection of family histories would become
important to molecular work on the genetics of some cancers.96 After years in the wild-
erness, Lynch was to see widespread acceptance of the genetic nature of a number of ‘‘his’’
cancers, albeit a genetic nature quite different to that which he had originally imagined.97
This is not to say that the new geneticists wholly embraced Lynch. It is true that he was
eventually honoured with having a number of familial, cancerous syndromes named after
96On the identification of cancer genes, see
Kevin Davies and Michael White, Breakthrough:
the race to find the breast cancer gene, New York,
John Wiley, 1996. For an account of longer
history of the molecularizing of cancer research,
see Jean-Paul Gaudilliere, ‘The molecularization of
cancer etiology in the postwar United States:
instruments, politics and management’, in Soraya de
Chadarevian and Harmke Kamminga (eds.),
Molecularizing biology and medicine: new practices
and alliances, 1910s–1970s, Amsterdam, Harwood,
1998, pp. 139–70. On the impact of molecular genetics
on HNPCC, see Raul Antonio Necochea, ‘From cancer
families to HNPCC: Henry Lynch and the
transformations of hereditary cancer, 1975–1999’,
Bull. Hist. Med., in press.
97Nevertheless, there remained a complex
relationship between molecular biological and
older notions of genetics. For example, in the 1990s,
molecular biologists began to conceptualize
HNPCC not as a disease that ran in families, but one
with specific genetic components that could be
detected by genetic testing. However, the search for
HNPCC genes was in part dependent on the prior
identification by means of family studies of entities
called ‘‘cancer families’’, and the diagnosis of
HNPCC required that mutated genes be found
within a kin group identified as a ‘‘cancer family’’.
Genetic testing did not do away with older notions
of the ‘‘cancer family’’. See Necochea, op. cit., note
96 above.
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him.98 But suspicions remained that he had bargained his way into the molecular genetic
revolution with a resource—extensive family records—that molecular geneticists needed
for their studies, but that he did not have the technical skill or scientific credentials
necessary to take such research forward. Some critics also continued—and still con-
tinue—to regard his early work on heredity as dubious science. The irony of Lynch is
that while he came to be honoured as the one of the ‘‘fathers’’ of cancer genetics, his
‘‘children’’ sometimes quietly questioned his paternity.99
98Three syndromes are named after him: Lynch’s
syndromes I and II (syndromes involving a
familial predisposition to colorectal cancer), and
Lynch–Wiersma syndrome (a combination of
ichtyosis congenita and secondary male
hypogonadismus).
99Raul Antonio Necochea is working on Lynch’s
involvement with themolecular genetics of cancer. See
Necochea, op. cit., note 96 above.
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